阻塞性睡眠呼吸暂停低通气综合征的一期多平面手术治疗与血清标记物变化的研究
|
摘要
[目的]探讨一期多平面手术治疗阻塞性睡眠呼吸暂停低通气综合征(OSAHS)的手术疗效。[方法]对190例OSAHS患者(2个平面以上狭窄)进行鼻腔手术、舌体消融、悬雍垂腭咽成形术、硬腭截短、Repose骨螺钉舌根和(或)舌骨悬吊手术方式中的二项或二项以上的联合手术,后进行6个月随访,比较资料完整的81例患者手术前后多导睡眠监测及X线测量下气道的参数,评价疗效。[结果]81例患者手术前后平均最低血氧饱和度由(0.71±0.01)提高至(0.82±0.07),差异均有统计学意义(t值分别为18.32、11.04,P值均<0.01)。下咽气道间隙由(12.1±3.2)mm增加至(16.9±2.6)mm,后气道间隙由(9.2±3.3)mm增加至(15.6±2.4)mm,差异均有统计学意义(t值分别为2.5、7.6,P值分别小于0.014和0.000)。治愈28例(AHI<5次／h),占39.5%,有效19例(AHI>20次／h但降低幅度≥50%),占23.5%,无效2例(AHI降低幅度<50%),占2.4%；治愈和显效率达74.1%。[结论]一期多平面手术是治疗OSAHS患者的有效手术方法。
[目的]研究重度OSAHS患者采用一期多平面手术治疗前后血清中血管紧张素II (angiotensin II, AngⅡ)、新喋呤(neopterin, Npt)、抵抗素(resistin)、S100β浓度的变化,评估手术治疗对这些因子的影响,探讨OSAHS与AngⅡ、Npt、抵抗素、S100β之间的关系。[方法] 2006年5月-2009年07月于我院住院的重度OSAHS患者30例一期多平面手术治疗前及术后六个月的外周血样本,并采集30例正常健康者外周血样本,采用ELISA方法检测血清AngⅡ、Npt、抵抗素、S100β蛋白水平。[结果]1. AngⅡ与最低SaO2、收缩压、AHI的变化有一定线性关系。随着AHI次数的增加,患者血清Npt浓度也增加。抵抗素与BMI的变化有一定线性关系,随着BMI的增加,抵抗素浓度增加。2. OSAHS患者术前AngⅡ、Npt、抵抗素、s100β蛋白浓度均高于健康对照组(P<0.05).3. OSAHS患者手术治疗后血清AngⅡ、Npt、抵抗素、S100β蛋白浓度均有不同程度下降(P<0.05)。[结论]1.一期多平面手术后患者血压下降与AngⅡ浓度降低,从而ET-1释放减少有关,AngⅡ可能在OSAHS的血压变化中起一定作用。2.NPT是一个与OSAHS病情严重程度相关的因子,可以用来评估OSAS病情,评价手术效果。3. OSAHS患者手术后6个月,血清中抵抗素浓度显著降低,可能与术后患者体重减低有关。4. OSAHS患者术前S100β蛋白浓度显著高于对照组,采用手术治疗6个月后,S100β蛋白浓度显著降低。可能与患者术后日间嗜睡症状缓解,记忆力明显升高有关。
Objective To treat obstructive sleep apnea-hypopnea syndrome (OSAHS) with one stage multilevel operation and evaluate treating effect. Methods One hundred and ninety patients of OSAHS (who have at least 2 obstruction levels) were treat with tongue coblation+uvulopalatopharyngoplasty+hard palate shortening+Repose suspension. The length of follow up was 6 months and complete data of 81 patients was collected. Apnea hypopnea index (AHI), lowest oxygen percent saturation (LSaO2), body mass index (BMI), vallecula epiglottica-lateral pharyngeal wall (V-LPW) and pharyngeal airway space (PAS) was used for diagnosis and evaluation. Results The LSaO2 of 81 patients increased from (0.71±0.01) to (0.82±0.07) (x±s),t=18.32.11.04, P＜0.01.The AHI reduced from (0.632±0.007) to (0.794±0.006),t=4.1, P=0.000. The V-LPW increased from (12.1±3.2) mm to (16.9±2.6) mm (t=2.5, P=0.014). PAS increased from (9.2±3.3) mm to (15.6±2.4) mm (t=7.6, P=0.000). The total effective rate is 74.1%. Conclusion one stage multilevel operation is an effective method of safety, simplicity.
Objective To treat obstructive sleep apnea-hypopnea syndrome(OSAHS) with one stage multilevel operation and evaluate the consistency change in angiotensin II, AngⅡ, neopterin, resistin, S100β. Methods Thirty patients of OSAHS were treat with tongue coblation+uvulopalatopharyngoplasty+hard palate shortening+Repose suspension. The serum of the the patients and normal people were taken before opration and 6 months later. ELISA was taken to evaluate the consistency change in angiotensin II, AngⅡ, neopterin, resistin, S100β. Results 1. AngⅡwas related with the LSaO2, systolic pressure, AHI.The Npt increased with AHI. Resistin increased with the BMI.2.The level of angiotensinⅡ, AngⅡ, neopterin, resistin, S100βin OSAHS patients were higher than control group (P＜0.05).3. The level of angiotensin II, AngⅡ, neopterin, resistin, S100βdecreased after opration (P<0.05).Conclusion 1. The systolic pressure decreased with Ang II level after one stage multilevel operation. AngⅡmight related with the change of the BP.2. NPT was related with the svere of OSAHS and might be used to evaluate the svere of OSAHS and the therapeutic effectiveness of the operation.
[目的]研究重度OSAHS患者采用一期多平面手术治疗前后血清中血管紧张素II (angiotensin II, AngⅡ)、新喋呤(neopterin, Npt)、抵抗素(resistin)、S100β浓度的变化,评估手术治疗对这些因子的影响,探讨OSAHS与AngⅡ、Npt、抵抗素、S100β之间的关系。[方法] 2006年5月-2009年07月于我院住院的重度OSAHS患者30例一期多平面手术治疗前及术后六个月的外周血样本,并采集30例正常健康者外周血样本,采用ELISA方法检测血清AngⅡ、Npt、抵抗素、S100β蛋白水平。[结果]1. AngⅡ与最低SaO2、收缩压、AHI的变化有一定线性关系。随着AHI次数的增加,患者血清Npt浓度也增加。抵抗素与BMI的变化有一定线性关系,随着BMI的增加,抵抗素浓度增加。2. OSAHS患者术前AngⅡ、Npt、抵抗素、s100β蛋白浓度均高于健康对照组(P<0.05).3. OSAHS患者手术治疗后血清AngⅡ、Npt、抵抗素、S100β蛋白浓度均有不同程度下降(P<0.05)。[结论]1.一期多平面手术后患者血压下降与AngⅡ浓度降低,从而ET-1释放减少有关,AngⅡ可能在OSAHS的血压变化中起一定作用。2.NPT是一个与OSAHS病情严重程度相关的因子,可以用来评估OSAS病情,评价手术效果。3. OSAHS患者手术后6个月,血清中抵抗素浓度显著降低,可能与术后患者体重减低有关。4. OSAHS患者术前S100β蛋白浓度显著高于对照组,采用手术治疗6个月后,S100β蛋白浓度显著降低。可能与患者术后日间嗜睡症状缓解,记忆力明显升高有关。
Objective To treat obstructive sleep apnea-hypopnea syndrome (OSAHS) with one stage multilevel operation and evaluate treating effect. Methods One hundred and ninety patients of OSAHS (who have at least 2 obstruction levels) were treat with tongue coblation+uvulopalatopharyngoplasty+hard palate shortening+Repose suspension. The length of follow up was 6 months and complete data of 81 patients was collected. Apnea hypopnea index (AHI), lowest oxygen percent saturation (LSaO2), body mass index (BMI), vallecula epiglottica-lateral pharyngeal wall (V-LPW) and pharyngeal airway space (PAS) was used for diagnosis and evaluation. Results The LSaO2 of 81 patients increased from (0.71±0.01) to (0.82±0.07) (x±s),t=18.32.11.04, P＜0.01.The AHI reduced from (0.632±0.007) to (0.794±0.006),t=4.1, P=0.000. The V-LPW increased from (12.1±3.2) mm to (16.9±2.6) mm (t=2.5, P=0.014). PAS increased from (9.2±3.3) mm to (15.6±2.4) mm (t=7.6, P=0.000). The total effective rate is 74.1%. Conclusion one stage multilevel operation is an effective method of safety, simplicity.
Objective To treat obstructive sleep apnea-hypopnea syndrome(OSAHS) with one stage multilevel operation and evaluate the consistency change in angiotensin II, AngⅡ, neopterin, resistin, S100β. Methods Thirty patients of OSAHS were treat with tongue coblation+uvulopalatopharyngoplasty+hard palate shortening+Repose suspension. The serum of the the patients and normal people were taken before opration and 6 months later. ELISA was taken to evaluate the consistency change in angiotensin II, AngⅡ, neopterin, resistin, S100β. Results 1. AngⅡwas related with the LSaO2, systolic pressure, AHI.The Npt increased with AHI. Resistin increased with the BMI.2.The level of angiotensinⅡ, AngⅡ, neopterin, resistin, S100βin OSAHS patients were higher than control group (P＜0.05).3. The level of angiotensin II, AngⅡ, neopterin, resistin, S100βdecreased after opration (P<0.05).Conclusion 1. The systolic pressure decreased with Ang II level after one stage multilevel operation. AngⅡmight related with the change of the BP.2. NPT was related with the svere of OSAHS and might be used to evaluate the svere of OSAHS and the therapeutic effectiveness of the operation.
引文
1. 上海市医学会呼吸病分会睡眠呼吸疾病学组.上海市30岁以上人群阻塞性睡眠呼吸暂停低通气综合征流行病学调查.中华结核和呼吸杂志,2003,26(5)：268—272.
2. Young T, Skatrud J, Peppard P.Risk factors for obstructive sleep apnea in adults.JAMA,2004,291(16):2013-2016.
3. Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea:a 7-year follow-up.Am J Respir Crit Care Med,2002,166(5):159-165.
4. Punjabi NM, Sorkin JD, Katzel LI, et al.Sleep-disordered breathing and insulin resistance in middle-aged and overweight men.Am J Respir Crit Care Med,2002,165(5):677-682.
5. Sateia MJ.Neuropsychological impairment and quality of life in obstructive sleep apnea.Clin Chest Med,2003,24(2):249-259.
6. Li KK.Surgical therapy for adult obstructive sleep apnea.Sleep Med Rev,2005,9(3):201-209.
7. Powell N. Upper airway surgery does have a major role in the treatment of obstr-uctive sleep apnea:"the tail end of the dog".J Clin Sleep Med,2005, 1(3):236-240.
8. Phillips B.Upper airway surgery does not have a major role in the treatment of sleep apnea.J Clin Sleep Med,2005,1(3):241-245.
9. Woodson BT, Robinson S, Lim HJ. Transpalatal advancement pharynogoplasty outcomes compared with uvulopalatopharygoplasty. Otolaryngol Head Neck Surg,2005,133(2):211-217.
10.中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉头颈外科学分会咽喉学组.阻塞性睡眠呼吸暂停低通气综合征诊断和外科治疗指南.中华耳鼻咽喉科头颈外科杂志,2009,44：95-96.
11. Yosef Segal, Atul Malhotra and Giora Pillar. Upper airway length may be associated with the severity of obstructive sleep apnea syndrome. Sleep and Breathing,2008,12(4):311-316.
12. Paul M, Macey, Rajesh Kumar. Brain Structure in OSA[J].SLEEP,2008, 31(7):967-977.
13.张震康.阻塞性睡眠呼吸暂停综合征.口腔颌面外科学.第4版.北京：人民卫生出版社,2000：336-340.
14. Ryan CF, Dickson RI, Lowe AA, et al. Upper airway measurements predict response to uvulopalatopharyngoplasty in obstructive sleep apnea. Laryngoscope,1990,100:248-253.
15. Marshall NS, Wong KK, Liu PY, et al. Sleep apnea as an independent risk factor for all-cause mortality:the Busselton Health Study. Sleep,2008,31: 1079-1085.
16.韩德民,王军,叶京英,等.腭咽成形术中保留悬雍垂的意义.中华耳鼻咽喉科杂志,2000,35：215-218.
17. Han DM, Ye JY, Wang J, et al.Revised uvuloplatopharyngoplasty with uvula presservation and its clinical study. ORL,2005,67:213-219.
18.林忠辉.阻塞性睡眠呼吸暂停低通气综合征进展.中国耳鼻咽喉头颈外科,2004,11：43-45.
19. Sher AE, Schechtman KB, Piccirillo JF. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep,1996,19:156-177.
20. Friedman M, Ibrahim H, Joseph NJ. Staging of obstructive sleep apnea/hypopnea syndrome:a guide to appropriate treatment. Laryngoscope, 2004,114:454-459.
21.张庆泉,宋西成,张天振,等.颈前进路舌根手术加悬雍垂腭咽成形术治疗重症阻塞性睡眠呼吸暂停低通气综合征.中华耳鼻咽喉头颈外科杂志,2005,40：704-705.
22.易红良,殷善开,鲁文莺,等.重度阻塞性睡眠呼吸暂停低通气综合征的联合手术治疗.中华耳鼻咽喉头颈外科杂志,2006,41：89-94.
23.王宇,张颖,张陛丞,等.睡眠呼吸暂停低通综合征治疗依从性的相关因素分析.临床耳鼻咽喉头颈外科杂志,2007,21：1140-1141.
24.韩德民.睡眠呼吸障碍疾病外科治疗的思考.中华耳鼻咽喉头颈外科杂志,2007,42(2)：81-82.
1. 上海市医学会呼吸病分会睡眠呼吸疾病学组.上海市30岁以上人群阻塞性睡眠呼吸暂停低通气综合征流行病学调查.中华结核和呼吸杂志,2003,26(5)：268—272.
2. Young T, Skatrud J,Peppard P.Risk factors for obstructive sleep apnea in adults. JAMA,2004,291(16):2013-2016.
3. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardio vascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med.2001,163:19-25.
4. Milleron, O, Pilliere, R, Foucher, A, et al Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004,25,728-734.
5. Peker, Y, Carlson, J, Hedner, J Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006,28,596-602.
6. Arzt M.Young T.Finn L, et al.Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med.2005, 172:1447-1451.
7. 中华医学会耳鼻咽喉科学分会,中华耳鼻咽喉科杂志编委会.阻塞性睡眠呼吸暂停低通气综合征诊断依据和疗效评定标准暨悬雍垂腭咽成形术适应证(杭州).中华耳鼻咽喉科杂志,2002,37(6)：403-404.
8. Stradling JR,Crosby JH.Relation between systemic hypertension and sleep hypoxemia or snoring:analysis in 748 men drawn from general practice.Br Med J,1990,300 (1):75-78.
9. Shepard JW Jr.Cardiorespiratory changes in obstructive sleep apnea (M).In: Kryger MH,Roth T,Dement WC,ed. Principles and practice of sleep medicine (M).2nd ed.Philadelphia:WB saunders Co,1994:657-666.
10. Shamsuzzaman AS,Gersh BJ,Somers VK.Obstructive sleep apnea: impli- cations for cardiac and vascular disease. JAMA,2003,290 (14):1906-1914.
11. Roux F,D Ambrosio C,Mohsenin V. Sleep-related breathing Diso-rders and cardiovascular disease:Am J Med,2000,108(5):396-402.
12.李延忠,张万荣,王廷础,等.·OSAHS并发高血压患者血管紧张素转换酶基因多态性及血清紧张素Ⅱ水平测定.临床耳鼻喉科杂志,2004,18(8)：456-459.
13.杜以明.持续气道正压通气对睡眠呼吸暂停综合征患者外周血内皮素及血管紧张素Ⅱ水平的影响,山东大学,2005,10-20.
14. Schumacher, M, Eber, B, Tatzber, F, et al Neopterin levels in patients with coronary artery disease. Atherosclerosis 1992,94,87-88.
15. Schumacher, M, Halwachs, G, Tatzber, F, et al Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol 1997, 30,703-707.
16. Gupta, S, Fredericks, S, Schwartzman, RA, et al Serum neopterin in acute coronary syndromes. Lancet 1997,349,1252-1253.
17.金哲秀,王嵬民,张昌秋,等.血清新喋呤与急性冠状动脉综合征之间的关系,放射免疫学杂志,2004,17,324-326.
18. Avanzas, P, Arroyo-Espliguero, R, Quiles, J, et al Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J 2005,26,457-463.
19. van Haelst, PL, Liem, A, van Boven, AJ, et al Usefulness of elevated neopterin and C-reactive protein levels in predicting cardiovascular events in patients with non-Q-wave myocardial infarction. Am J Cardiol 2003,92, 1201-1203.
20. Ursavas A, Karadag M, Oral AY, Demirdogen E, Oral HB, Ege E. Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea. Respir Med.2008,102(8):1193-1197.
21. N. M. Punjabi, B. A. Beamer, A. Jain, Elevated Levels of Neopterin in Sleep-Disordered Breathing Chest (2007) 132(4):1124-1130.
22. Stappan CM,Baley ST,Bhat S,et al。 The homone resistin links obesity to diabetes[J]。 Nature,2001,109 (18):307-312.
23. Km KH,Lee K,Moon Y S,et al。 A cysteine-rich adipose tissue specific secretory factor inhibits adipocyte differentiation。 Biol Chen,2001,276 (6): 11252-11256.
24. Haugen F,Jorgensen A,Drevon CA,et al.Inhibition by insulin of resistin gene expression in 3T3-L_1 adipocytes.FEBS Lett,2001,507(1):105-108.
25. Lng C,Kndblom J,Wennbo H,et al. Increased resistin expression in the adipose tissue of male prolactin transgenic mice and in male mice with elevated androgen levels. FEBS Letters,2001,507,147-150.
26. Delhanty PJ,Mesotten D,Mcdougoll F,et al. Growth Hormone Rapidly Induces Resistin Gene Expression in White Adipose Tissue of Spontaneous Dwarf (SDR) Rats.Endocrinology,2002,143(16):2445-2448.
27. Fasshauer, M., Klein, J., Neumann, S, et al.Isoproterenol inhibits resistin gene expression through a G S-protein-coupled pathway in 3T3-L1 adipocytes.FEBS Lett,2001,500 (1/2):60-63.
28. asshauer M,Klen J,Neumann S,et al.Tumor necrosis factor alpha is a negative regular of resistin gene expression and secretion in 3T3-L_1adipocytes.Biolchem Biophys Res Commun,2001,288(4):1027-1031.
29. Juan CC,Au LC,Fang V S,et al.Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids.Biolchen Biophys Res Commun,2001,289(5):1328-1333.
30.王玫,郑明秀.阻塞性睡眠呼吸暂停综合征与血清抵抗素的相关性研究.昆明医学院学报,2007,(1)：40-42.
31. Sajkov D, Marshall R, Walker P, et al. Sleep aponea related hypoxia is associated with cognitive distubances in patients with tetraplegia. Spinal Cord,1998,36:231-239.
32.冯慧伟.阻塞性睡眠呼吸暂停低通气综合征患者记忆力改变与S100 β及NSE相关性研究.山东大学。2006：9-17.
1. Redline S. Tishler PV, Harls MG, et al. acial difiefences in sleep-disordered breathing in African-Americans and Caucasiansl[J]. AmJ Respir Crit Care Med,1997,155(1):186-192.
2. Lam B, Ip MS, Tench E, et al. Craniofaeial profile in Asian and white subjects with obstructive sleep apnoea[J]. Thorax,2005,60(6):504-510.
3. Bayram N, Ciftci B, Durmza T, et aI_Effects of continuous positive airway pressure therapy on left ventricular function assessed by tissue Doppler imaging in patients with Obstructive sleep apnoea syndrome[J]. Eur J Echocardiogr,2008,10(8):257.
4. Somers VK, Mark AL, Zavala DC, Abboud FM. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 1989,67:2101-2106.
5. Somers VK, Mark AL, Zavala DC, Abboud FM. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol 1989,67:2095-2100.
6. Narkiewicz K, van de Borne PJ, Montano N, Dyken ME, Phillips BG, Somers VK. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 1998,97:943-945.
7. Mark AL, Victor RG, Nerhed C, Wallin BG Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ Res 1985,57:461-469.
8. Wallin G Intraneural recording and autonomic function in man. In:Bannister R, editor. Autonomic failure. London:Oxford University Press; 1983,36-51.
9. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995,96:1897-1904.
10. Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Oda N, Tanaka A,et al. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med 2007,175:612-617.
11. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T,Accurso V, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002,105:2462-2464.
12. Larkin EK, Rosen CL, Kirchner HL, Storfer-Isser A, Emancipator JL, Johnson NL, et al. Variation of C-reactive protein levels in adolescents:Association with sleep-disordered breathing and sleep duration.Circulation 2005,111:1978-1984.
13. Punjabi NM, Beamer BA. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 2007,30:29-34.
14. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005,112:2660-2667.
15. Iesato K, Tatsumi K, Saibara T, Nakamura A, Terada J, Tada Y, et al. Decreased lipoprotein lipase in obstructive sleep apnea syndrome.Circ J 2007, 71:1293-1298.
16. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea.Circulation 2000,102: 2607-2610.
17. Sprague RS, Thiemermann C, Vane JR. Endogenous endotheliumderived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits.Proc Natl Acad Sci USA 1992,89:8711-8715.
18. Leeman M, de Beyl VZ, Biarent D, Maggiorini M, Melot C, Naeije R. Inhibition of cyclooxygenase and nitric oxide synthase in hypoxic vasoconstriction and oleic acid-induced lung injury. Am J Respir Crit Care Med 1999,159(5 Pt 1):1383-1390.
19. Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008,117:2270-2278.
20. YoungT, Palta M, Dempsey J, et al. The occulTence of sleep-disordered breathing among middle-aged adults[J]. N Engl J Med,1993,328(17): 1230-1235.
21. Ip MS, Lain B, Lauder IJ, et al. A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong[J]. Chest,2001, 119(1):62-69.
22. Ip MS, Lam B, Tang LC, et al. A community study of sleep-disordered breathing in middle-aged Chinese women in Hong Kong:prevalence and gender diferences[J]. Chest,2004,125(1):127-134.
23. Udwadia ZF, Doshi AV, Lonkar SG, et al. Prevalence of sleep-dis-ordered breathing and sleep apnea in middle-aged urban Indian men[J]. Am J Respir Crit Care Med,2004,169(2):168-173.
24. Sharma SK, Kumpawat S, Banga A, et al. Prevalence and risk factom of obstructive sleep apnea syndrome in a population of Delhi, India[J]. Chest, 2006,130(1):149-156.
25.张庆,何权瀛,杜秋艳,等.承德市区居民睡眠呼吸暂停低通气综合征患病率人户调查[J].中华结核和呼吸杂志,2003,26(5)：2733-275.
26.上海市医学会呼吸病学分会睡眠呼吸疾病学组.上海市30岁以上人群阻塞性睡眠呼吸暂停低通气综合征流行病学调查[J].中华结核和呼吸杂志,2003,26(5)：268-272.
27. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea:a population health perspective[J]. Am J Respir Cfit Care Med,2002, 165(9):1217-1239.
28. Young T, Evans L, Finn L, et al. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women[J]. Sleep,1997,20(9):705-706.
29. Hiestand DM, Brits P, Goldman M, et al. Prevalence of symptoms and risk of slep apneainthe US population:Resultsfrom the national sleep foundation sleep in America 2005 poll[J]. Chest,2006,130(3):780-786.
30. Bixler EO, Vgontzas AN, Ten Have T, et ol. Efects of age on sleep apneain men:I. Prevalence and severity[J]. Am J Respir Crit Care Med,1998, 157(1):144-148.
31. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women:efects of gender[J]. Am J Respir Crit Care Med,2001, 163(3 Pt 1):608-613.
32. Scanlan MF, Roebuck T, Little PJ, et al. Effect of moderate alcohol upon obstructive sleep apnoea[J]. Eur Respir J,2000,16(5):909-913.
33. Peppard PE, Austin D, Brown RL. Association of alcohol consumption and sleep disordered breathing in men and women[J]. J Clin Sleep Med,2007, 3(3):265-270.
34. Franklin KA, Gislason T, Omenaas E, et al. The influence of active and passive smoking on habitual snoring[J]. Am J Respir Crit Care Med,2004, 170(7):799-803.
35. Izci B, Vennelle M, Liston WA, et al. Sleep-disordered breathing and upper airway size in pregnancy and post-partum[J]. Eur Respit J,2006,27(2): 321-327.
36. Sahin FK,Koken G, Cosar E, et al. Obstructive sleep apnea in pregnancy and fetal outcome[J]. Int J Gynaecol Obstet,2008,100(2):141-146.
37. Redline S, Tosteson T, Tishler PV, et al. Studies in 山 e genetics of obstructive sleep apnea. Familial aggregation of symptoms associated with sleep, related breathing disturbances[J]. Am Rev Respir Dis.1992.145(2 pt 1):440-444.
38. Buxbaum SG, Elston RC, Tishler PV, et al. Genetics of the apnea hypopnea index in Caucasians and African Americans:I.Segregation analysis[J]. Genet Epidemiol,2002,22(3):243-253.
39. Palmer LJ, Buxbaura SG, Larkin EK, et al. Whole genome scan for obstructive sleep apnea and obesity in African-American families [J]. Am J Respir Crit Care Med,2004,169(12):1314-1321.
40. Szyszk0 A, Franceschini C, Gonzalez-Zuelgaray J. Reliability of a Holter-based methodology fOr evaluation of sleep apnea syndrome[J]. Europace,2009,11(1):94.
41. Silverberg DS, Oksenberg A, Iaina A. Sleep-related breathing disorders as a major cause of essential hypertension: Fact or fiction?Curr Opin Nephrol Hypertens 1998,7:353-357.
42. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R,Niroumand M, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001,19:2271-2277.
43. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension.N Engl J Med 2000,342:1378-1384.
44. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA 2000,283: 1829-1836.
45. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD.Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999,160:1101-1106.
46. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure:Types and their prevalences, consequences, and presentations.Circulation 1998,97: 2154-2159.
47. Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, et al.Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007,49:1625-1631.
48. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, et al. Association of nocturnal arrhythmias with sleep-disordered breathing:The Sleep Heart Health Study. Am J Respir Crit Care Med 2006,173:910-916.
49. Tilkian AG, Guilleminault C, Schroeder JS, Lehrman KL, Simmons FB, Dement WC. Sleep-induced apnea syndrome:Prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am J Med 1977,63: 348-358.
50. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983,52:490-494.
51. Miller WP. Cardiac arrhythmias and conduction disturbances in the sleep apnea syndrome: Prevalence and significance. Am J Med 1982,73:317-321.
52. Flemons WW, Remmers JE, Gillis AM. Sleep apnea and cardiac arrhythmias: Is there a relationship? Am Rev Respir Dis 1993,148:618-621.
53. Roche F, Xuong AN, Court-Fortune I, Costes F, Pichot V, Duverney D, et al. Relationship among the severity of sleep apnea syndrome,cardiac arrhythmias, and autonomic imbalance. Pacing Clin Electrophysiol 2003,26: 669-677.
54. Hoffstein V, Mateika S. Cardiac arrhythmias, snoring, and sleep apnea. Chest 1994,106:466-471.
55. Becker H, Brandenburg U, Peter JH, Von Wichert P. Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure. Am J Respir Crit Care Med 1995, 151:215-218.
56. Koehler U, Becker HF, Grimm W, Heitmann J, Peter JH, Schafer H. Relations among hypoxemia, sleep stage, and bradyarrhythmia during obstructive sleep apnea. Am Heart J 2000,139:142-148.
57. Koshino Y, Satoh M, Katayose Y, Yasuda K, Tanigawa T, Takeyasu N, et al. Association of sleep-disordered breathing and ventricular arrhythmias in patients without heart failure. Am J Cardiol 2008,101:882-886.
58. Buxton AE, Lee KL, Hafley GE, Wyse G, Fisher JD, Lehmann MH, et al. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease:An analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation 2002, 106:2466-2472.
59. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H,et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter automatic defibrillator implantation trial investigators. N EnglJ Med 1996,335:1933-1940.
60. Harbison J, O'Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome:Effects of nasal continuous positive airway pressure therapy. Chest 2000,118:591-595.
61. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure.Circulation 2000,101: 392-397.
62. Shepard JW Jr, Garrison MW, Grither DA, Dolan GF. Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest 1985,88:335-340.
63. Wolk R, Kara T, Somers VK. Sleep-disordered breathing and cardiovascular disease. Circulation 2003,108:9-12.
64. Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ,Ballman KV, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003,107:2589-2594.
65.]Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P. Sleepdisordered breathing in men with coronary artery disease. Chest 1996,109:659-663.
66. Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for allcause mortality: The Busselton Health Study. Sleep 2008,31:1079-1085.
67. Yumino D, Wang H, Floras JS, Newton GE, Mak S, Ruttanaumpawan P, et al. Relationship between sleep apnea and mortality in patients with ischemic heart failure. Heart 2009,95:819-824.
68. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al. Sleep-disordered breathing and cardiovascular disease:Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001,163:19-25.
69. Kuniyoshi FH, Garcia-Touchard A, Gami AS, Romero-Corral A,van der Walt C, Pusalavidyasagar S, et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol 2008,52:343-346.
70. Ishibashi Y, OSAHSda N, Sekiduka H, Izumo M, Shimozato T, Hayashi A, et al. Peak time of acute coronary syndrome in patients with sleep disordered breathing. J Cardiol 2009,53:164-170.
71. Arzt M, Yount T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of. Am J Respir Crit Care Med 2005,172:1447-1451.
72. Urbano F, Roux F, Schindler J, Mohsenin V. Impaired cerebral autoregulation in obstructive sleep apnea. J Appl Physiol 2008,105:1852-1857.
73. Nasr N, Traon AP, Czosnyka M, Tiberge M, Schmidt E, Larrue V.Cerebral autoregulation in patients with obstructive sleep apnea syndrome during wakefulness. Eur J Neurol 2009,16:386-391.
74. Harbison J, Gibson GJ, Birchall D, Zammit-Maempel I, Ford GA. White matter disease and sleep-disordered breathing after acute. Neurology 2003, 61:959-963.
75. Klingelhofer J, Hajak G, Sander D, Schulz-Varszegi M, Ruther E,Conrad B. Assessment.of intracranial hemodynamics in sleep apneasyndrome.1992,23: 1427-1433.
76. Lehoux S, Tedgui A. Signal transduction of mechanical stresses in the vascular wall. Hypertension 1998,32:338-345.
77. Jiang Y, Kohara K, Hiwada K. Association between risk factors for atherosclerosis and mechanical forces in carotid artery.2000,31:2319-2324.
78. Bernath I, McNamara P, Szternak N, Szakacs Z, Kes P, Terray-Horvath A, et al. Hyperviscosity as a possible cause of positive acoustic evoked potential findings in patients with sleep apnea:A dual electrophysiological and hemorheological study. Sleep Med 2008,10:361-367.
79. Foster GE, Hanly PJ, Ostrowski M, Poulin MJ. Effects of continuous positive airway pressure on cerebral vascular response to hypoxia in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2007,175:720-725.
80. Lee SA, Amis TC, Byth K, Larcos G, Kairaitis K, Robinson TD, et al. Heavy snoring as a cause of carotid artery atherosclerosis. Sleep 2008,31:1207-1213.
81. Good DC, Henkle JQ, Gelber D, Welsh J, Verhulst S. Sleep-disordered breathing and poor functional outcome after 1996,27:252-259.
82. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM,Mohsenin V. Obstructive sleep apnea as a risk factor for and death. N Engl J Med 2005, 353:2034-2041.
83. Sahlin C, Sandberg O, Gustafson Y, Bucht G, Carlberg B, Stenlund H, et al. Obstructive sleep apnea is a risk factor for death in patients with:A 10-year follow-up. Arch Intern Med 2008,168:297-301.
84. Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA. Increased risk of stroke in patients with coronary artery disease and sleep apnea: A 10-year follow-up. Circulation 2008,118:955-960.
85. Kasasbeh E, Chi DS, Krishnaswamy G. Inflammatory aspects of sleep apnea and their cardiovascular consequences. South Med J,2006,99:58-67.
86. Entzian P, Linnemann K, Schlaak M, et al. Obstructive sleep apnea syndrome and eircadiand rh-hms of hormones and cytokines. AmJRespirCritCareMed,1996,153(3):1080-1086.
87.牛红丽,马利军,王海播,等.OSAHS合并高血压患者血清炎症因子浓度与血压的关系.中国实用医药,2008,30(3)：58-60.
88.刘志,华琦,李东宝,等.老年高血压病并发阻塞性睡眠呼吸暂停综合征患者血压特点及与炎症因子的关系.心脏杂志,2008,20(5)：574-576,587.
89. Moiler DS, Lind P, Strunge B, et al. Abnormal vasoactive hot. mones and 24··hour blood pressure in obstructive sleep apnea. Am JHypertens,2003, 16:274-280.
90.胡雪君,康健,肖丹,等.持续气道正压通气对阻塞性睡眠呼吸暂停综合征患者血管活性物质的影响.中华结核和呼吸杂志,2002,25(1)：36-38.
91. Calhoun DA, Nishizaka MK, Zaman MA et al. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest, 2004,125(1):112-117.
92.李海燕,赵秋良,韩晓攀,等.阻塞性睡眠呼吸暂停综合征患者自由基 损伤与高血压的关系.山东大学耳鼻喉眼学报,2006,(6)：527-529.
93.平芬,马小宁,韩书芝,等.阻塞性睡眠呼吸暂停低通气综合征患者脂质过氧化反应的研究.中华结核和呼吸杂志,2006,29(4)：274-275.
94.田蓉,平芬,高凤岐,等.阻塞性睡眠呼吸暂停低通气综合征合并高血压患者血内皮素、一氧化氮及肿瘤坏死因子水平的变化.国际呼吸杂志,2006,26(6)：401-404.
95.李延忠,王廷础,卢红霞,等.阻塞性睡眠呼吸暂停低通气综合征合并高血压患者睡眠结构分析及血清内皮素-1的测定.中华耳鼻咽喉科杂志,2004,39(2)：116.119.
96.张志岷.血管内皮生长因子在老年OSAHS患者高血压形成中的作用.中国现代医生,2008,46(36)：24-25.
97.马秀芬,平芬,刘美霞,等.血栓素A2、前列环素与阻塞性睡眠呼吸暂停低通气综合征及其合并高血压的相关性研究.临床荟萃,2005,(24)：1396-1399.
98. Kimura H,Niijima M,Abe Y, et al. Compensatory excretion of prostacyclin and thromboxane metabolites in obstructive sleep apnea syndrome. Intern Med,1998,37(2):127-133.
99.常桂娟,李南方,王新玲,等.高血压病合并阻塞性睡眠呼吸暂停综合征患者血浆同型半胱氨酸水平的临床观察.中华临床医师杂志(电子版),2009,(2)：196-202.
100.徐春华,林勇,王静.阻塞性睡眠呼吸暂停低通气综合征合并高血压患者血浆同型半胱氨酸水平的测定.现代医学,2007,35(3)：202-204.
lO1.Bokinsky G, Miller M, Ault K, et al. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pmssum.Chest,1995,108:625-630.
102.张艳玲,雷飞,杨中华.高血压合并阻塞性睡眠呼吸暂停综合征与血清 5-羟色胺水平的关系.华西医学,2008,23(1)：43-44.
103.Schumacher, M, Eber, B, Tatzber, F, et al Neopterin levels in patients with coronary artery disease. Atherosclerosis 1992,94,87-88.
104. Schumacher, M, Halwachs, G, Tatzber, F, et al Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol 1997, 30,703-707.
105.Gupta, S, Fredericks, S, Schwartzman, RA, et al Serum neopterin in acute coronary syndromes. Lancet 1997,349,1252-1253.
106.金哲秀,王嵬民,张昌秋,安丽萍,伍海安,血清新喋呤与急性冠状动脉综合征之间的关系,放射免疫学杂志,2004年04期.
107.Avanzas, P, Arroyo-Espliguero, R, Quiles, J, et al Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J 2005,26,457-463.
108.van Haelst, PL, Li em, A, van Boven, AJ, et al Usefulness of elevated neopterin and C-reactive protein levels in predicting cardiovascular events in patients with non-Q-wave myocardial infarction. Am J Cardiol 2003,92, 1201-1203.
109.Ursavas A, Karadag M, Oral AY, Demirdogen E, Oral HB, Ege E. Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea. Respir Med.2008 Aug,102(8):1193-1197.
110.N. M. Punjabi, B. A. Beamer, A. Jain, Elevated Levels of Neopterin in Sleep-Disordered Breathing Chest (2007) 132(4):1124-1130.
111.STAPPAN CM,BALEY ST,BHAT S,et al. The homone resistin links obesity to diabetes[J]。Nature,2001,109 (18):307-312.
112.KM KH, LEEK, MOON Y S, et al。 A cysteine-rich adipose tissue specific secretory factor inhibits adipocyte differentiation[J]。 Biol Chen,2001,276 (6):11252-11256.
113.王玫,郑明秀.阻塞性睡眠呼吸暂停综合征与血清抵抗素的相关性研究.昆明医学院学报,2007,(1)：40-42.
114.Sajkov D, Marshall R, Walker P, et al.Sleep aponea related hypoxia is associated with cognitive distubances in patients with tetraplegia. Spinal Cord, 1998,36:231-239.
115.Tiner BD.Surgical management of obstructive sleep apnea [J].J Oral Maxillofac Surg,1996,54(9):1109.
116.Lofaso F, Coste A, d'Ortho MP, et al. Nasal obstruction as a risk factor for sleep apnoea syndrome[J]. Eur Respir J,2000,16(4):639-643.
117.Kohler M,Bloch KE, Stradling JR. The role of the nose in the patho genesis of obstructive sleep apnea[J]. Curt Opin Otolaryngol Head Neck Surg,2009, 17(1):33-37.
118.Fujita S,Conway W, Zoriek F, et al. Surgical correction of anatomic azbnormalities in obstru ctive sleep apnea syndrome: uvulopalatopharyng0plasty[J]. Otolaryngol Head Neck Surg,1981,89(6): 923-934.
119.Sher AE, Schechtman KB, Piccirillo JF. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome[J]. Sleep,1996,19(2):156-177.
120.Fairbanks DN. Uvulopalatopharyngoplasty:strategies for success and safety[J]. Ear Nose Throat J,1993,72(1):46-7.50-51.
121.Fairbanks DN. Uvulopalatopharyngoplasty:strategies for success and safety[J]. Ear Nose Throat J,1993,72(1):46-7.50-51.
122.Friedman M, Ibrahim HZ, Vidyasagar R, et al. Z-palatoplasty(ZPP):a technique for patients without tonsils[J]. Otolaryngol Head Neck Surg,2004, 131(1):89-100.
123.Yi HL, Yin SK, Zhang YJ, et al. Z-palatopharyngoplasty for obstructive sleep apnea/hypopnea syndrome[J]. Otolaryngol Head Neck Surg,2009, 140(5):640-645.
124.Woodson BT, Toohill RJ. TranspalatM advancement pharyngoplasty for obstructive sleep apnea[J]. Laryngoscope,1993,103(3):269-276.
125.Powell NB, Riley RW, Troell RJ, et al. Radiofequency volumetric reduction of the tongue. A porcine pilot study for the treatment of obstructive sleep apnea syndrome[J]. Chest,1997,1 11f5):1348-1355.
126.Back LJ, Hytonen ML, Roine RP, et al. Radiofrequeney ablation treatment of soft palate for patients with snoring:a systematic review of effectiveness and adverse efects[J]. Laryngoscope,2009,119(6):1241-1250.
127.Woodson BT, Fujita S. Clinical experience with lingualplasty as part of the treatment of severe obstructive sleep apnea[J]. Otolaryngol Head Neck Surg, 1992,107(1):40-48.
128.Mickelson SA, Rosenthal L. Midline glossectomy and epiglottidectomy for obstructive sleep apnea syndrome[J]. Laryngoscope,1997,107(5): 614-619.
129.Hsieh TH, Fang TJ, Li HY, et al. Simultaneous midline laser glossectomy with palatopharyngeal surgery for obstructive sleep apnoea syndrome[J]. Int J Clin Pract JT,2005,59(4):501-503.
130.Riley RW, Powell NB, Guilleminauh C. Inferior sagittal osteotomy of the mandible with hyoid myotomy·suspension:a new procedure for obstructive sleep apnea[J]Otolaryng Head Neck Surg,1986,94(5):589-593.
131.Yin SK, Yi HL, Lu wY, et al. Genioglossus advancement and hyoid suspension plus uvulopalatopharyngoplasty for severe OSAHS fJ1. Otolaryngol Head Neck Surg,2007,136(4):626-631.
132.王林娥,殷善开,孙晓强,等.改良颏舌肌前移术治疗阻塞性睡眠呼吸 暂停低通气综合征[J].临床耳鼻咽喉头颈外科杂志,2009,23(7)：325-327.
133.Yin SK, Yi HL Im wY, et al. Anatomic and spiral computed tomographic study of the genial tubercles for genioglossus advancement[J]. Otolaryngol Head Neck Surg,2007,136(4):632-637.
134.易红良,殷善开,鲁文莺,等.国产颏棘环钻系统行颏舌肌前移术[J].中国耳鼻咽喉头颈外科,2005,12(10)：622-624.
135.Miller FR, Watson D, Boseley M. The role of the Genial Bone Advancement Trephine system in conjunction with uvulopalatopharyngoplasty in the muhilevel management of obstructive sleep apnea[J]. Otolaryngol Head Neck Surg,2004,130(1):73-79.
136.Li KK, Riley RW, Powell NB, et al. Maxillomandibular advancement for persistent obstru ctive sleep apnea after phase I surgery in patients without maxillomandibular de, ficiency[J]. Laryngoscope,2000,110(10 Pt 1): 1684-1688.
137.Prinsell JR. Maxillomandibular advancement surgery for obstructive sleep apnea syndrome[J]. J Am Dent Assoc,2002,133(11):1489-1497.
138.Guilleminault C, Li KK. Maxillomandibular expansion for the treatment of sleep-disordered breathing:preliminaryresult[J]. Laryngoscope,2004,1 14(5):893-896.
139.McCarthy JG, Katzen JT, Hopper R, et al. The first decade of mandibular distraction:lessons we have learned[J]. Plast Reconstr Surg, 2002,110(7):1704-1713.
140.易红良,殷善开.牵引成骨术在OSAHS治疗中的应用[J].国外医学：耳鼻咽喉科学分册,2004,28(5)：276-279.
2. Young T, Skatrud J, Peppard P.Risk factors for obstructive sleep apnea in adults.JAMA,2004,291(16):2013-2016.
3. Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea:a 7-year follow-up.Am J Respir Crit Care Med,2002,166(5):159-165.
4. Punjabi NM, Sorkin JD, Katzel LI, et al.Sleep-disordered breathing and insulin resistance in middle-aged and overweight men.Am J Respir Crit Care Med,2002,165(5):677-682.
5. Sateia MJ.Neuropsychological impairment and quality of life in obstructive sleep apnea.Clin Chest Med,2003,24(2):249-259.
6. Li KK.Surgical therapy for adult obstructive sleep apnea.Sleep Med Rev,2005,9(3):201-209.
7. Powell N. Upper airway surgery does have a major role in the treatment of obstr-uctive sleep apnea:"the tail end of the dog".J Clin Sleep Med,2005, 1(3):236-240.
8. Phillips B.Upper airway surgery does not have a major role in the treatment of sleep apnea.J Clin Sleep Med,2005,1(3):241-245.
9. Woodson BT, Robinson S, Lim HJ. Transpalatal advancement pharynogoplasty outcomes compared with uvulopalatopharygoplasty. Otolaryngol Head Neck Surg,2005,133(2):211-217.
10.中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉头颈外科学分会咽喉学组.阻塞性睡眠呼吸暂停低通气综合征诊断和外科治疗指南.中华耳鼻咽喉科头颈外科杂志,2009,44：95-96.
11. Yosef Segal, Atul Malhotra and Giora Pillar. Upper airway length may be associated with the severity of obstructive sleep apnea syndrome. Sleep and Breathing,2008,12(4):311-316.
12. Paul M, Macey, Rajesh Kumar. Brain Structure in OSA[J].SLEEP,2008, 31(7):967-977.
13.张震康.阻塞性睡眠呼吸暂停综合征.口腔颌面外科学.第4版.北京：人民卫生出版社,2000：336-340.
14. Ryan CF, Dickson RI, Lowe AA, et al. Upper airway measurements predict response to uvulopalatopharyngoplasty in obstructive sleep apnea. Laryngoscope,1990,100:248-253.
15. Marshall NS, Wong KK, Liu PY, et al. Sleep apnea as an independent risk factor for all-cause mortality:the Busselton Health Study. Sleep,2008,31: 1079-1085.
16.韩德民,王军,叶京英,等.腭咽成形术中保留悬雍垂的意义.中华耳鼻咽喉科杂志,2000,35：215-218.
17. Han DM, Ye JY, Wang J, et al.Revised uvuloplatopharyngoplasty with uvula presservation and its clinical study. ORL,2005,67:213-219.
18.林忠辉.阻塞性睡眠呼吸暂停低通气综合征进展.中国耳鼻咽喉头颈外科,2004,11：43-45.
19. Sher AE, Schechtman KB, Piccirillo JF. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep,1996,19:156-177.
20. Friedman M, Ibrahim H, Joseph NJ. Staging of obstructive sleep apnea/hypopnea syndrome:a guide to appropriate treatment. Laryngoscope, 2004,114:454-459.
21.张庆泉,宋西成,张天振,等.颈前进路舌根手术加悬雍垂腭咽成形术治疗重症阻塞性睡眠呼吸暂停低通气综合征.中华耳鼻咽喉头颈外科杂志,2005,40：704-705.
22.易红良,殷善开,鲁文莺,等.重度阻塞性睡眠呼吸暂停低通气综合征的联合手术治疗.中华耳鼻咽喉头颈外科杂志,2006,41：89-94.
23.王宇,张颖,张陛丞,等.睡眠呼吸暂停低通综合征治疗依从性的相关因素分析.临床耳鼻咽喉头颈外科杂志,2007,21：1140-1141.
24.韩德民.睡眠呼吸障碍疾病外科治疗的思考.中华耳鼻咽喉头颈外科杂志,2007,42(2)：81-82.
1. 上海市医学会呼吸病分会睡眠呼吸疾病学组.上海市30岁以上人群阻塞性睡眠呼吸暂停低通气综合征流行病学调查.中华结核和呼吸杂志,2003,26(5)：268—272.
2. Young T, Skatrud J,Peppard P.Risk factors for obstructive sleep apnea in adults. JAMA,2004,291(16):2013-2016.
3. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardio vascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med.2001,163:19-25.
4. Milleron, O, Pilliere, R, Foucher, A, et al Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004,25,728-734.
5. Peker, Y, Carlson, J, Hedner, J Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006,28,596-602.
6. Arzt M.Young T.Finn L, et al.Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med.2005, 172:1447-1451.
7. 中华医学会耳鼻咽喉科学分会,中华耳鼻咽喉科杂志编委会.阻塞性睡眠呼吸暂停低通气综合征诊断依据和疗效评定标准暨悬雍垂腭咽成形术适应证(杭州).中华耳鼻咽喉科杂志,2002,37(6)：403-404.
8. Stradling JR,Crosby JH.Relation between systemic hypertension and sleep hypoxemia or snoring:analysis in 748 men drawn from general practice.Br Med J,1990,300 (1):75-78.
9. Shepard JW Jr.Cardiorespiratory changes in obstructive sleep apnea (M).In: Kryger MH,Roth T,Dement WC,ed. Principles and practice of sleep medicine (M).2nd ed.Philadelphia:WB saunders Co,1994:657-666.
10. Shamsuzzaman AS,Gersh BJ,Somers VK.Obstructive sleep apnea: impli- cations for cardiac and vascular disease. JAMA,2003,290 (14):1906-1914.
11. Roux F,D Ambrosio C,Mohsenin V. Sleep-related breathing Diso-rders and cardiovascular disease:Am J Med,2000,108(5):396-402.
12.李延忠,张万荣,王廷础,等.·OSAHS并发高血压患者血管紧张素转换酶基因多态性及血清紧张素Ⅱ水平测定.临床耳鼻喉科杂志,2004,18(8)：456-459.
13.杜以明.持续气道正压通气对睡眠呼吸暂停综合征患者外周血内皮素及血管紧张素Ⅱ水平的影响,山东大学,2005,10-20.
14. Schumacher, M, Eber, B, Tatzber, F, et al Neopterin levels in patients with coronary artery disease. Atherosclerosis 1992,94,87-88.
15. Schumacher, M, Halwachs, G, Tatzber, F, et al Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol 1997, 30,703-707.
16. Gupta, S, Fredericks, S, Schwartzman, RA, et al Serum neopterin in acute coronary syndromes. Lancet 1997,349,1252-1253.
17.金哲秀,王嵬民,张昌秋,等.血清新喋呤与急性冠状动脉综合征之间的关系,放射免疫学杂志,2004,17,324-326.
18. Avanzas, P, Arroyo-Espliguero, R, Quiles, J, et al Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J 2005,26,457-463.
19. van Haelst, PL, Liem, A, van Boven, AJ, et al Usefulness of elevated neopterin and C-reactive protein levels in predicting cardiovascular events in patients with non-Q-wave myocardial infarction. Am J Cardiol 2003,92, 1201-1203.
20. Ursavas A, Karadag M, Oral AY, Demirdogen E, Oral HB, Ege E. Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea. Respir Med.2008,102(8):1193-1197.
21. N. M. Punjabi, B. A. Beamer, A. Jain, Elevated Levels of Neopterin in Sleep-Disordered Breathing Chest (2007) 132(4):1124-1130.
22. Stappan CM,Baley ST,Bhat S,et al。 The homone resistin links obesity to diabetes[J]。 Nature,2001,109 (18):307-312.
23. Km KH,Lee K,Moon Y S,et al。 A cysteine-rich adipose tissue specific secretory factor inhibits adipocyte differentiation。 Biol Chen,2001,276 (6): 11252-11256.
24. Haugen F,Jorgensen A,Drevon CA,et al.Inhibition by insulin of resistin gene expression in 3T3-L_1 adipocytes.FEBS Lett,2001,507(1):105-108.
25. Lng C,Kndblom J,Wennbo H,et al. Increased resistin expression in the adipose tissue of male prolactin transgenic mice and in male mice with elevated androgen levels. FEBS Letters,2001,507,147-150.
26. Delhanty PJ,Mesotten D,Mcdougoll F,et al. Growth Hormone Rapidly Induces Resistin Gene Expression in White Adipose Tissue of Spontaneous Dwarf (SDR) Rats.Endocrinology,2002,143(16):2445-2448.
27. Fasshauer, M., Klein, J., Neumann, S, et al.Isoproterenol inhibits resistin gene expression through a G S-protein-coupled pathway in 3T3-L1 adipocytes.FEBS Lett,2001,500 (1/2):60-63.
28. asshauer M,Klen J,Neumann S,et al.Tumor necrosis factor alpha is a negative regular of resistin gene expression and secretion in 3T3-L_1adipocytes.Biolchem Biophys Res Commun,2001,288(4):1027-1031.
29. Juan CC,Au LC,Fang V S,et al.Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids.Biolchen Biophys Res Commun,2001,289(5):1328-1333.
30.王玫,郑明秀.阻塞性睡眠呼吸暂停综合征与血清抵抗素的相关性研究.昆明医学院学报,2007,(1)：40-42.
31. Sajkov D, Marshall R, Walker P, et al. Sleep aponea related hypoxia is associated with cognitive distubances in patients with tetraplegia. Spinal Cord,1998,36:231-239.
32.冯慧伟.阻塞性睡眠呼吸暂停低通气综合征患者记忆力改变与S100 β及NSE相关性研究.山东大学。2006：9-17.
1. Redline S. Tishler PV, Harls MG, et al. acial difiefences in sleep-disordered breathing in African-Americans and Caucasiansl[J]. AmJ Respir Crit Care Med,1997,155(1):186-192.
2. Lam B, Ip MS, Tench E, et al. Craniofaeial profile in Asian and white subjects with obstructive sleep apnoea[J]. Thorax,2005,60(6):504-510.
3. Bayram N, Ciftci B, Durmza T, et aI_Effects of continuous positive airway pressure therapy on left ventricular function assessed by tissue Doppler imaging in patients with Obstructive sleep apnoea syndrome[J]. Eur J Echocardiogr,2008,10(8):257.
4. Somers VK, Mark AL, Zavala DC, Abboud FM. Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 1989,67:2101-2106.
5. Somers VK, Mark AL, Zavala DC, Abboud FM. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol 1989,67:2095-2100.
6. Narkiewicz K, van de Borne PJ, Montano N, Dyken ME, Phillips BG, Somers VK. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 1998,97:943-945.
7. Mark AL, Victor RG, Nerhed C, Wallin BG Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ Res 1985,57:461-469.
8. Wallin G Intraneural recording and autonomic function in man. In:Bannister R, editor. Autonomic failure. London:Oxford University Press; 1983,36-51.
9. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995,96:1897-1904.
10. Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Oda N, Tanaka A,et al. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med 2007,175:612-617.
11. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T,Accurso V, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002,105:2462-2464.
12. Larkin EK, Rosen CL, Kirchner HL, Storfer-Isser A, Emancipator JL, Johnson NL, et al. Variation of C-reactive protein levels in adolescents:Association with sleep-disordered breathing and sleep duration.Circulation 2005,111:1978-1984.
13. Punjabi NM, Beamer BA. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 2007,30:29-34.
14. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005,112:2660-2667.
15. Iesato K, Tatsumi K, Saibara T, Nakamura A, Terada J, Tada Y, et al. Decreased lipoprotein lipase in obstructive sleep apnea syndrome.Circ J 2007, 71:1293-1298.
16. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea.Circulation 2000,102: 2607-2610.
17. Sprague RS, Thiemermann C, Vane JR. Endogenous endotheliumderived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits.Proc Natl Acad Sci USA 1992,89:8711-8715.
18. Leeman M, de Beyl VZ, Biarent D, Maggiorini M, Melot C, Naeije R. Inhibition of cyclooxygenase and nitric oxide synthase in hypoxic vasoconstriction and oleic acid-induced lung injury. Am J Respir Crit Care Med 1999,159(5 Pt 1):1383-1390.
19. Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008,117:2270-2278.
20. YoungT, Palta M, Dempsey J, et al. The occulTence of sleep-disordered breathing among middle-aged adults[J]. N Engl J Med,1993,328(17): 1230-1235.
21. Ip MS, Lain B, Lauder IJ, et al. A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong[J]. Chest,2001, 119(1):62-69.
22. Ip MS, Lam B, Tang LC, et al. A community study of sleep-disordered breathing in middle-aged Chinese women in Hong Kong:prevalence and gender diferences[J]. Chest,2004,125(1):127-134.
23. Udwadia ZF, Doshi AV, Lonkar SG, et al. Prevalence of sleep-dis-ordered breathing and sleep apnea in middle-aged urban Indian men[J]. Am J Respir Crit Care Med,2004,169(2):168-173.
24. Sharma SK, Kumpawat S, Banga A, et al. Prevalence and risk factom of obstructive sleep apnea syndrome in a population of Delhi, India[J]. Chest, 2006,130(1):149-156.
25.张庆,何权瀛,杜秋艳,等.承德市区居民睡眠呼吸暂停低通气综合征患病率人户调查[J].中华结核和呼吸杂志,2003,26(5)：2733-275.
26.上海市医学会呼吸病学分会睡眠呼吸疾病学组.上海市30岁以上人群阻塞性睡眠呼吸暂停低通气综合征流行病学调查[J].中华结核和呼吸杂志,2003,26(5)：268-272.
27. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea:a population health perspective[J]. Am J Respir Cfit Care Med,2002, 165(9):1217-1239.
28. Young T, Evans L, Finn L, et al. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women[J]. Sleep,1997,20(9):705-706.
29. Hiestand DM, Brits P, Goldman M, et al. Prevalence of symptoms and risk of slep apneainthe US population:Resultsfrom the national sleep foundation sleep in America 2005 poll[J]. Chest,2006,130(3):780-786.
30. Bixler EO, Vgontzas AN, Ten Have T, et ol. Efects of age on sleep apneain men:I. Prevalence and severity[J]. Am J Respir Crit Care Med,1998, 157(1):144-148.
31. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women:efects of gender[J]. Am J Respir Crit Care Med,2001, 163(3 Pt 1):608-613.
32. Scanlan MF, Roebuck T, Little PJ, et al. Effect of moderate alcohol upon obstructive sleep apnoea[J]. Eur Respir J,2000,16(5):909-913.
33. Peppard PE, Austin D, Brown RL. Association of alcohol consumption and sleep disordered breathing in men and women[J]. J Clin Sleep Med,2007, 3(3):265-270.
34. Franklin KA, Gislason T, Omenaas E, et al. The influence of active and passive smoking on habitual snoring[J]. Am J Respir Crit Care Med,2004, 170(7):799-803.
35. Izci B, Vennelle M, Liston WA, et al. Sleep-disordered breathing and upper airway size in pregnancy and post-partum[J]. Eur Respit J,2006,27(2): 321-327.
36. Sahin FK,Koken G, Cosar E, et al. Obstructive sleep apnea in pregnancy and fetal outcome[J]. Int J Gynaecol Obstet,2008,100(2):141-146.
37. Redline S, Tosteson T, Tishler PV, et al. Studies in 山 e genetics of obstructive sleep apnea. Familial aggregation of symptoms associated with sleep, related breathing disturbances[J]. Am Rev Respir Dis.1992.145(2 pt 1):440-444.
38. Buxbaum SG, Elston RC, Tishler PV, et al. Genetics of the apnea hypopnea index in Caucasians and African Americans:I.Segregation analysis[J]. Genet Epidemiol,2002,22(3):243-253.
39. Palmer LJ, Buxbaura SG, Larkin EK, et al. Whole genome scan for obstructive sleep apnea and obesity in African-American families [J]. Am J Respir Crit Care Med,2004,169(12):1314-1321.
40. Szyszk0 A, Franceschini C, Gonzalez-Zuelgaray J. Reliability of a Holter-based methodology fOr evaluation of sleep apnea syndrome[J]. Europace,2009,11(1):94.
41. Silverberg DS, Oksenberg A, Iaina A. Sleep-related breathing disorders as a major cause of essential hypertension: Fact or fiction?Curr Opin Nephrol Hypertens 1998,7:353-357.
42. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R,Niroumand M, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001,19:2271-2277.
43. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension.N Engl J Med 2000,342:1378-1384.
44. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA 2000,283: 1829-1836.
45. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD.Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999,160:1101-1106.
46. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure:Types and their prevalences, consequences, and presentations.Circulation 1998,97: 2154-2159.
47. Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, et al.Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007,49:1625-1631.
48. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, et al. Association of nocturnal arrhythmias with sleep-disordered breathing:The Sleep Heart Health Study. Am J Respir Crit Care Med 2006,173:910-916.
49. Tilkian AG, Guilleminault C, Schroeder JS, Lehrman KL, Simmons FB, Dement WC. Sleep-induced apnea syndrome:Prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am J Med 1977,63: 348-358.
50. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983,52:490-494.
51. Miller WP. Cardiac arrhythmias and conduction disturbances in the sleep apnea syndrome: Prevalence and significance. Am J Med 1982,73:317-321.
52. Flemons WW, Remmers JE, Gillis AM. Sleep apnea and cardiac arrhythmias: Is there a relationship? Am Rev Respir Dis 1993,148:618-621.
53. Roche F, Xuong AN, Court-Fortune I, Costes F, Pichot V, Duverney D, et al. Relationship among the severity of sleep apnea syndrome,cardiac arrhythmias, and autonomic imbalance. Pacing Clin Electrophysiol 2003,26: 669-677.
54. Hoffstein V, Mateika S. Cardiac arrhythmias, snoring, and sleep apnea. Chest 1994,106:466-471.
55. Becker H, Brandenburg U, Peter JH, Von Wichert P. Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure. Am J Respir Crit Care Med 1995, 151:215-218.
56. Koehler U, Becker HF, Grimm W, Heitmann J, Peter JH, Schafer H. Relations among hypoxemia, sleep stage, and bradyarrhythmia during obstructive sleep apnea. Am Heart J 2000,139:142-148.
57. Koshino Y, Satoh M, Katayose Y, Yasuda K, Tanigawa T, Takeyasu N, et al. Association of sleep-disordered breathing and ventricular arrhythmias in patients without heart failure. Am J Cardiol 2008,101:882-886.
58. Buxton AE, Lee KL, Hafley GE, Wyse G, Fisher JD, Lehmann MH, et al. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease:An analysis of patients enrolled in the multicenter unsustained tachycardia trial. Circulation 2002, 106:2466-2472.
59. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H,et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia: Multicenter automatic defibrillator implantation trial investigators. N EnglJ Med 1996,335:1933-1940.
60. Harbison J, O'Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome:Effects of nasal continuous positive airway pressure therapy. Chest 2000,118:591-595.
61. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure.Circulation 2000,101: 392-397.
62. Shepard JW Jr, Garrison MW, Grither DA, Dolan GF. Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest 1985,88:335-340.
63. Wolk R, Kara T, Somers VK. Sleep-disordered breathing and cardiovascular disease. Circulation 2003,108:9-12.
64. Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ,Ballman KV, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003,107:2589-2594.
65.]Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P. Sleepdisordered breathing in men with coronary artery disease. Chest 1996,109:659-663.
66. Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for allcause mortality: The Busselton Health Study. Sleep 2008,31:1079-1085.
67. Yumino D, Wang H, Floras JS, Newton GE, Mak S, Ruttanaumpawan P, et al. Relationship between sleep apnea and mortality in patients with ischemic heart failure. Heart 2009,95:819-824.
68. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al. Sleep-disordered breathing and cardiovascular disease:Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001,163:19-25.
69. Kuniyoshi FH, Garcia-Touchard A, Gami AS, Romero-Corral A,van der Walt C, Pusalavidyasagar S, et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol 2008,52:343-346.
70. Ishibashi Y, OSAHSda N, Sekiduka H, Izumo M, Shimozato T, Hayashi A, et al. Peak time of acute coronary syndrome in patients with sleep disordered breathing. J Cardiol 2009,53:164-170.
71. Arzt M, Yount T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of. Am J Respir Crit Care Med 2005,172:1447-1451.
72. Urbano F, Roux F, Schindler J, Mohsenin V. Impaired cerebral autoregulation in obstructive sleep apnea. J Appl Physiol 2008,105:1852-1857.
73. Nasr N, Traon AP, Czosnyka M, Tiberge M, Schmidt E, Larrue V.Cerebral autoregulation in patients with obstructive sleep apnea syndrome during wakefulness. Eur J Neurol 2009,16:386-391.
74. Harbison J, Gibson GJ, Birchall D, Zammit-Maempel I, Ford GA. White matter disease and sleep-disordered breathing after acute. Neurology 2003, 61:959-963.
75. Klingelhofer J, Hajak G, Sander D, Schulz-Varszegi M, Ruther E,Conrad B. Assessment.of intracranial hemodynamics in sleep apneasyndrome.1992,23: 1427-1433.
76. Lehoux S, Tedgui A. Signal transduction of mechanical stresses in the vascular wall. Hypertension 1998,32:338-345.
77. Jiang Y, Kohara K, Hiwada K. Association between risk factors for atherosclerosis and mechanical forces in carotid artery.2000,31:2319-2324.
78. Bernath I, McNamara P, Szternak N, Szakacs Z, Kes P, Terray-Horvath A, et al. Hyperviscosity as a possible cause of positive acoustic evoked potential findings in patients with sleep apnea:A dual electrophysiological and hemorheological study. Sleep Med 2008,10:361-367.
79. Foster GE, Hanly PJ, Ostrowski M, Poulin MJ. Effects of continuous positive airway pressure on cerebral vascular response to hypoxia in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2007,175:720-725.
80. Lee SA, Amis TC, Byth K, Larcos G, Kairaitis K, Robinson TD, et al. Heavy snoring as a cause of carotid artery atherosclerosis. Sleep 2008,31:1207-1213.
81. Good DC, Henkle JQ, Gelber D, Welsh J, Verhulst S. Sleep-disordered breathing and poor functional outcome after 1996,27:252-259.
82. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM,Mohsenin V. Obstructive sleep apnea as a risk factor for and death. N Engl J Med 2005, 353:2034-2041.
83. Sahlin C, Sandberg O, Gustafson Y, Bucht G, Carlberg B, Stenlund H, et al. Obstructive sleep apnea is a risk factor for death in patients with:A 10-year follow-up. Arch Intern Med 2008,168:297-301.
84. Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA. Increased risk of stroke in patients with coronary artery disease and sleep apnea: A 10-year follow-up. Circulation 2008,118:955-960.
85. Kasasbeh E, Chi DS, Krishnaswamy G. Inflammatory aspects of sleep apnea and their cardiovascular consequences. South Med J,2006,99:58-67.
86. Entzian P, Linnemann K, Schlaak M, et al. Obstructive sleep apnea syndrome and eircadiand rh-hms of hormones and cytokines. AmJRespirCritCareMed,1996,153(3):1080-1086.
87.牛红丽,马利军,王海播,等.OSAHS合并高血压患者血清炎症因子浓度与血压的关系.中国实用医药,2008,30(3)：58-60.
88.刘志,华琦,李东宝,等.老年高血压病并发阻塞性睡眠呼吸暂停综合征患者血压特点及与炎症因子的关系.心脏杂志,2008,20(5)：574-576,587.
89. Moiler DS, Lind P, Strunge B, et al. Abnormal vasoactive hot. mones and 24··hour blood pressure in obstructive sleep apnea. Am JHypertens,2003, 16:274-280.
90.胡雪君,康健,肖丹,等.持续气道正压通气对阻塞性睡眠呼吸暂停综合征患者血管活性物质的影响.中华结核和呼吸杂志,2002,25(1)：36-38.
91. Calhoun DA, Nishizaka MK, Zaman MA et al. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest, 2004,125(1):112-117.
92.李海燕,赵秋良,韩晓攀,等.阻塞性睡眠呼吸暂停综合征患者自由基 损伤与高血压的关系.山东大学耳鼻喉眼学报,2006,(6)：527-529.
93.平芬,马小宁,韩书芝,等.阻塞性睡眠呼吸暂停低通气综合征患者脂质过氧化反应的研究.中华结核和呼吸杂志,2006,29(4)：274-275.
94.田蓉,平芬,高凤岐,等.阻塞性睡眠呼吸暂停低通气综合征合并高血压患者血内皮素、一氧化氮及肿瘤坏死因子水平的变化.国际呼吸杂志,2006,26(6)：401-404.
95.李延忠,王廷础,卢红霞,等.阻塞性睡眠呼吸暂停低通气综合征合并高血压患者睡眠结构分析及血清内皮素-1的测定.中华耳鼻咽喉科杂志,2004,39(2)：116.119.
96.张志岷.血管内皮生长因子在老年OSAHS患者高血压形成中的作用.中国现代医生,2008,46(36)：24-25.
97.马秀芬,平芬,刘美霞,等.血栓素A2、前列环素与阻塞性睡眠呼吸暂停低通气综合征及其合并高血压的相关性研究.临床荟萃,2005,(24)：1396-1399.
98. Kimura H,Niijima M,Abe Y, et al. Compensatory excretion of prostacyclin and thromboxane metabolites in obstructive sleep apnea syndrome. Intern Med,1998,37(2):127-133.
99.常桂娟,李南方,王新玲,等.高血压病合并阻塞性睡眠呼吸暂停综合征患者血浆同型半胱氨酸水平的临床观察.中华临床医师杂志(电子版),2009,(2)：196-202.
100.徐春华,林勇,王静.阻塞性睡眠呼吸暂停低通气综合征合并高血压患者血浆同型半胱氨酸水平的测定.现代医学,2007,35(3)：202-204.
lO1.Bokinsky G, Miller M, Ault K, et al. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pmssum.Chest,1995,108:625-630.
102.张艳玲,雷飞,杨中华.高血压合并阻塞性睡眠呼吸暂停综合征与血清 5-羟色胺水平的关系.华西医学,2008,23(1)：43-44.
103.Schumacher, M, Eber, B, Tatzber, F, et al Neopterin levels in patients with coronary artery disease. Atherosclerosis 1992,94,87-88.
104. Schumacher, M, Halwachs, G, Tatzber, F, et al Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol 1997, 30,703-707.
105.Gupta, S, Fredericks, S, Schwartzman, RA, et al Serum neopterin in acute coronary syndromes. Lancet 1997,349,1252-1253.
106.金哲秀,王嵬民,张昌秋,安丽萍,伍海安,血清新喋呤与急性冠状动脉综合征之间的关系,放射免疫学杂志,2004年04期.
107.Avanzas, P, Arroyo-Espliguero, R, Quiles, J, et al Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J 2005,26,457-463.
108.van Haelst, PL, Li em, A, van Boven, AJ, et al Usefulness of elevated neopterin and C-reactive protein levels in predicting cardiovascular events in patients with non-Q-wave myocardial infarction. Am J Cardiol 2003,92, 1201-1203.
109.Ursavas A, Karadag M, Oral AY, Demirdogen E, Oral HB, Ege E. Association between serum neopterin, obesity and daytime sleepiness in patients with obstructive sleep apnea. Respir Med.2008 Aug,102(8):1193-1197.
110.N. M. Punjabi, B. A. Beamer, A. Jain, Elevated Levels of Neopterin in Sleep-Disordered Breathing Chest (2007) 132(4):1124-1130.
111.STAPPAN CM,BALEY ST,BHAT S,et al. The homone resistin links obesity to diabetes[J]。Nature,2001,109 (18):307-312.
112.KM KH, LEEK, MOON Y S, et al。 A cysteine-rich adipose tissue specific secretory factor inhibits adipocyte differentiation[J]。 Biol Chen,2001,276 (6):11252-11256.
113.王玫,郑明秀.阻塞性睡眠呼吸暂停综合征与血清抵抗素的相关性研究.昆明医学院学报,2007,(1)：40-42.
114.Sajkov D, Marshall R, Walker P, et al.Sleep aponea related hypoxia is associated with cognitive distubances in patients with tetraplegia. Spinal Cord, 1998,36:231-239.
115.Tiner BD.Surgical management of obstructive sleep apnea [J].J Oral Maxillofac Surg,1996,54(9):1109.
116.Lofaso F, Coste A, d'Ortho MP, et al. Nasal obstruction as a risk factor for sleep apnoea syndrome[J]. Eur Respir J,2000,16(4):639-643.
117.Kohler M,Bloch KE, Stradling JR. The role of the nose in the patho genesis of obstructive sleep apnea[J]. Curt Opin Otolaryngol Head Neck Surg,2009, 17(1):33-37.
118.Fujita S,Conway W, Zoriek F, et al. Surgical correction of anatomic azbnormalities in obstru ctive sleep apnea syndrome: uvulopalatopharyng0plasty[J]. Otolaryngol Head Neck Surg,1981,89(6): 923-934.
119.Sher AE, Schechtman KB, Piccirillo JF. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome[J]. Sleep,1996,19(2):156-177.
120.Fairbanks DN. Uvulopalatopharyngoplasty:strategies for success and safety[J]. Ear Nose Throat J,1993,72(1):46-7.50-51.
121.Fairbanks DN. Uvulopalatopharyngoplasty:strategies for success and safety[J]. Ear Nose Throat J,1993,72(1):46-7.50-51.
122.Friedman M, Ibrahim HZ, Vidyasagar R, et al. Z-palatoplasty(ZPP):a technique for patients without tonsils[J]. Otolaryngol Head Neck Surg,2004, 131(1):89-100.
123.Yi HL, Yin SK, Zhang YJ, et al. Z-palatopharyngoplasty for obstructive sleep apnea/hypopnea syndrome[J]. Otolaryngol Head Neck Surg,2009, 140(5):640-645.
124.Woodson BT, Toohill RJ. TranspalatM advancement pharyngoplasty for obstructive sleep apnea[J]. Laryngoscope,1993,103(3):269-276.
125.Powell NB, Riley RW, Troell RJ, et al. Radiofequency volumetric reduction of the tongue. A porcine pilot study for the treatment of obstructive sleep apnea syndrome[J]. Chest,1997,1 11f5):1348-1355.
126.Back LJ, Hytonen ML, Roine RP, et al. Radiofrequeney ablation treatment of soft palate for patients with snoring:a systematic review of effectiveness and adverse efects[J]. Laryngoscope,2009,119(6):1241-1250.
127.Woodson BT, Fujita S. Clinical experience with lingualplasty as part of the treatment of severe obstructive sleep apnea[J]. Otolaryngol Head Neck Surg, 1992,107(1):40-48.
128.Mickelson SA, Rosenthal L. Midline glossectomy and epiglottidectomy for obstructive sleep apnea syndrome[J]. Laryngoscope,1997,107(5): 614-619.
129.Hsieh TH, Fang TJ, Li HY, et al. Simultaneous midline laser glossectomy with palatopharyngeal surgery for obstructive sleep apnoea syndrome[J]. Int J Clin Pract JT,2005,59(4):501-503.
130.Riley RW, Powell NB, Guilleminauh C. Inferior sagittal osteotomy of the mandible with hyoid myotomy·suspension:a new procedure for obstructive sleep apnea[J]Otolaryng Head Neck Surg,1986,94(5):589-593.
131.Yin SK, Yi HL, Lu wY, et al. Genioglossus advancement and hyoid suspension plus uvulopalatopharyngoplasty for severe OSAHS fJ1. Otolaryngol Head Neck Surg,2007,136(4):626-631.
132.王林娥,殷善开,孙晓强,等.改良颏舌肌前移术治疗阻塞性睡眠呼吸 暂停低通气综合征[J].临床耳鼻咽喉头颈外科杂志,2009,23(7)：325-327.
133.Yin SK, Yi HL Im wY, et al. Anatomic and spiral computed tomographic study of the genial tubercles for genioglossus advancement[J]. Otolaryngol Head Neck Surg,2007,136(4):632-637.
134.易红良,殷善开,鲁文莺,等.国产颏棘环钻系统行颏舌肌前移术[J].中国耳鼻咽喉头颈外科,2005,12(10)：622-624.
135.Miller FR, Watson D, Boseley M. The role of the Genial Bone Advancement Trephine system in conjunction with uvulopalatopharyngoplasty in the muhilevel management of obstructive sleep apnea[J]. Otolaryngol Head Neck Surg,2004,130(1):73-79.
136.Li KK, Riley RW, Powell NB, et al. Maxillomandibular advancement for persistent obstru ctive sleep apnea after phase I surgery in patients without maxillomandibular de, ficiency[J]. Laryngoscope,2000,110(10 Pt 1): 1684-1688.
137.Prinsell JR. Maxillomandibular advancement surgery for obstructive sleep apnea syndrome[J]. J Am Dent Assoc,2002,133(11):1489-1497.
138.Guilleminault C, Li KK. Maxillomandibular expansion for the treatment of sleep-disordered breathing:preliminaryresult[J]. Laryngoscope,2004,1 14(5):893-896.
139.McCarthy JG, Katzen JT, Hopper R, et al. The first decade of mandibular distraction:lessons we have learned[J]. Plast Reconstr Surg, 2002,110(7):1704-1713.
140.易红良,殷善开.牵引成骨术在OSAHS治疗中的应用[J].国外医学：耳鼻咽喉科学分册,2004,28(5)：276-279.